SBI/Thrombin Plasma prep for Exosome precipitation (500 ?L at 500 U/mL)/TMEXO-1/100 Reactions
基因編輯
商品編號
TMEXO-1
品牌
SBI
公司
System Biosciences(SBI)
公司分類(lèi)
exosome isolation
商品信息
.img-style{heigth:450px;width:450px;}
Overview:
Efficient exosome isolation from plasma
“We therefore pursued the ExoQuick
?
method for further study, as these samples required much less sample input, a key benefit when working with clinical samples and mouse models
1
.”
?
When isolating exosomes from plasma, fibrinogen and fibrin can impede efficient recovery. By pre-treating plasma with thrombin, the fibrinogen can be converted to fibrin and easily pre-cleared by a simple centrifugation step. The resulting serum-like solution can now be treated with ExoQuick, original formulation, for quantitative exosome isolation that is compat
IBL
e with high-throughput methods.
Want to learn more about how ExoQuick works? Find out here.
Choose the right ExoQuick for your biofluid:
Catalog #
Product
Biofluid
EXOQ5A-1, EXOQ20A-1
The Original ExoQuick
For serum, plasma, and ascites fluid
EXOTC10A-1, EXOTC50A-1
ExoQuick-TC
?
For all other biofluids
EXOLP5A-1
ExoQuick-LP
For removing contaminating lipoprotein particles from plasma or serum before ExoQuick precipitation
EXOQ5TM-1
ExoQuick Plasma Prep with Thrombin
For de-fibrinating plasma before exosome isolation for efficient recovery and high yields
EXOCG50A-1
ExoQuick-CG
For preparing exosomes used in pre-clinical
in vivo
applications
EQPL10A-1, EQPL10TC
ExoQuick PLUS and ExoQuick-TC PLUS
For sensitive applications such as mass spectrometry, exosome labeling, and
in vivo
/
ex vivo
exosome delivery
REFERENCES
Chugh PE,
et al
. Systemically Circulating Viral and Tumor-Derived MicroRNAs in KSHV-Associated Malignancies.
PLoS Pathog.
2013.
9
(7): e1003484. PMCID: PMC3715412.
產(chǎn)品貨號:5052.0